TDC vs medical therapy
Secondary outcome:total serious adverse events at the end of · people with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
TDC showed no clear difference in secondary outcome:total serious adverse events at the end of compared with medical therapy (low certainty).
1 finding from 1 review
- Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of… 2015 · Cochrane Headline outcomes onlyRR 1.04 [0.88, 1.23]3 studies · 2303 participantsLow